![Samuel Hopkins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Samuel Hopkins
Keine laufenden Positionen mehr
Karriereverlauf von Samuel Hopkins
Ehemalige bekannte Positionen von Samuel Hopkins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2001 |
Parion Sciences, Inc.
![]() Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
SCYNEXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.10.2009 | - |
Ausbildung von Samuel Hopkins
Western University of Health Sciences | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCYNEXIS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Parion Sciences, Inc.
![]() Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Commercial Services |
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Samuel Hopkins
- Erfahrung